Clinical Trial Update: Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating bivalirudin as anticoagulant therapy during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heparin-induced Thrombocytopenia
• Thrombosis

Drugs mentioned

• Bivalirudin (bivalirudin)

Snippet

Sponsor: The Medicines Company | Conditions: Heparin-Induced Thrombocytopenia, Thrombosis | Phase 3 | Status: COMPLETED